ENTITY
Mega Lifesciences

Mega Lifesciences (MEGA TB)

68
Analysis
Health CareThailand
Mega Lifesciences PCL manufactures, markets and distributes nutritional and herbal supplement, OTC and ethical drugs. The Company produces products that range from treating internal issues to overall general health.
more
Refresh
04 Aug 2022 08:12Broker

Monthly Report - August 2022

We expect the SET Index to move up, with the support at 1,555/1,530 points and the resistance at 1,600/1,616 points, on the back of foreign...

Logo
173 Views
Share
04 Aug 2022 07:51Broker

Big Cap Tactical Picks - Aug 3, 2022

MEGA’s share price has rebounded by more than 5% over the past two weeks on the market’s expectations for a limited impact from Myanmar’s government

Logo
163 Views
Share
05 Jan 2022 10:33Broker

MEGA: Expect Growth Rate to Slow Down in 2022

We maintain BUY rating and roll over target price to Bt56 (+8% from previous TP) based on 25xPE’22E, a 15% discount from Thai health care peers.

Share
19 Nov 2018 14:44Broker

MEGA: 3Q18 Result Is Slightly Below Our Expectation

MEGA reported 3Q18 net profit of Bt255m (+4%YoY, -12%QoQ). 9M18 result accounts for 63% of our full year forecast and is slightly below our...

Share
12 Sep 2018 09:47Broker

MEGA: Supplement Maker Spreads Healthy Message in Booming Region

We initiate coverage on MEGA with a BUY rating and based on a target price of Bt43, which is derived from the DCF methodology (WACC 12.5% and...

Share
x